Windtree Therapeutics, Inc. WINT OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score

43/100

1/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

共有 50 笔近期内部人交易记录记录，涉及 Windtree Therapeutics, Inc. (WINT), 包括 37 笔买入 和 7 笔卖出. 内部人买入总额为 $2.12M 内部人卖出总额为 $2.16M.

近期活跃的重要内部人包括 Kelly Leanne, Fraser Craig, Pelletier Saundra L. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.

内部人交易记录 — WINT

日期	姓名	职位	交易类型	股数	平均价格	总价值	持股数量
2025-01-08	Kelly Leanne	Director	未知	-	-	-	-
2024-10-08	Fraser Craig	President and CEO	知情买入	5,431	$0.91	$4.94K	8,638
2024-08-13	Pelletier Saundra L	Director	未知	-	-	-	-
2024-08-13	Latkin Jed	Director	未知	-	-	-	-
2024-07-22	Fraser Craig	President and CEO	限制性股票授予 (RSU)	19	-	-	19
2024-07-22	Simonson Steven	SVP, Chief Medical Officer	限制性股票授予 (RSU)	13	-	-	13
2023-09-27	Fraser Craig	President and CEO	知情买入	2,500	$1.02	$2.55K	57,877
2023-09-26	Fraser Craig	President and CEO	知情买入	2,500	$0.90	$2.25K	55,377
2023-08-24	Mcandrew Jamie	VP, Controller, & CAO	处置	15,000	$1.21	$18.15K	-
2023-08-23	Scott Robert A	Director	限制性股票授予 (RSU)	2,033	-	-	2,133
2023-08-23	Fraser Craig	President and CEO	限制性股票授予 (RSU)	45,867	-	-	52,877
2023-08-23	Strobeck Mark	Director	限制性股票授予 (RSU)	2,300	-	-	2,300
2023-08-23	Simonson Steven	SVP, Chief Medical Officer	限制性股票授予 (RSU)	15,867	-	-	17,440
2023-08-23	Curtis Eric	SVP & COO	限制性股票授予 (RSU)	14,667	-	-	15,920
2023-08-23	Williams Leslie J.	Director	限制性股票授予 (RSU)	2,033	-	-	2,133
2023-08-23	Geffken Daniel E.	Director	限制性股票授予 (RSU)	2,033	-	-	2,175
2023-06-22	Strobeck Mark	Director	未知	-	-	-	-
2023-04-26	Fraser Craig	President and CEO	知情买入	1,497	$1.77	$2.65K	7,010
2023-04-25	Fraser Craig	President and CEO	知情买入	1,315	$1.89	$2.49K	5,513
2023-02-28	Fraser Craig	President and CEO	RSU 预扣税	334	-	-	4,198
2023-02-28	Simonson Steven	SVP, Chief Medical Officer	RSU 预扣税	100	-	-	1,573
2023-02-28	Curtis Eric	SVP & COO	RSU 预扣税	99	-	-	1,253
2023-02-28	Carman Diane	SVP & General Counsel	RSU 预扣税	99	-	-	1,227
2023-02-22	Huang James	Director	实值期权行权	1,112,308	$0.14	$156.95K	-
2023-01-27	Tattory John A	Officer	未知	-	-	-	-
2022-07-27	Fraser Craig	President and CEO	知情买入	2,500	$0.38	$949.75	226,558
2022-07-26	Fraser Craig	President and CEO	知情买入	2,500	$0.37	$935.00	224,058
2022-07-26	Hamill John P.	SVP & CFO	知情买入	3,000	$0.37	$1.1K	72,800
2022-06-30	Fraser Craig	President and CEO	知情买入	4,500	$0.43	$1.93K	221,558
2022-06-29	Fraser Craig	President and CEO	知情买入	7,000	$0.42	$2.91K	217,058
2022-06-07	Scott Robert A	Director	限制性股票授予 (RSU)	5,000	-	-	5,000
2022-06-07	Geffken Daniel E.	Director	限制性股票授予 (RSU)	5,000	-	-	7,069
2022-06-07	Huang James	Director	限制性股票授予 (RSU)	5,000	-	-	296,281
2022-06-07	Williams Leslie J.	Director	限制性股票授予 (RSU)	5,000	-	-	5,000
2022-03-16	Fraser Craig	President and CEO	知情买入	2,000	$0.98	$1.96K	210,058
2022-03-15	Fraser Craig	President and CEO	知情买入	3,000	$0.98	$2.94K	208,058
2022-03-15	Simonson Steven	SVP, Chief Medical Officer	知情买入	5,000	$1.00	$5K	83,602
2022-03-04	Fraser Craig	President and CEO	限制性股票授予 (RSU)	166,900	-	-	205,058
2022-03-04	Simonson Steven	SVP, Chief Medical Officer	限制性股票授予 (RSU)	66,300	-	-	78,602
2022-03-04	Curtis Eric	SVP & COO	限制性股票授予 (RSU)	66,300	-	-	67,591
2022-03-04	Hamill John P.	SVP & CFO	限制性股票授予 (RSU)	66,300	-	-	69,800
2022-03-04	Carman Diane	SVP & General Counsel	限制性股票授予 (RSU)	66,300	-	-	66,300
2021-12-30	Bioengine Capital Inc.	10 Percent Owner	知情卖出	1,239,088	$1.60	$1.98M	-
2021-12-30	Center Laboratories, Inc.	10 Percent Owner	知情买入	1,239,088	$1.60	$1.98M	1,239,088
2021-11-19	Fraser Craig	President and CEO	知情买入	930	$1.60	$1.49K	38,158
2021-11-18	Fraser Craig	President and CEO	知情买入	930	$1.61	$1.5K	37,228
2021-10-22	Fraser Craig	President and CEO	知情买入	3,000	$1.90	$5.7K	36,298
2021-10-19	Fraser Craig	President and CEO	知情买入	3,000	$1.91	$5.73K	33,298
2021-10-19	Huang James	Director	知情买入	50,000	$1.90	$95.14K	291,281
2021-07-01	Carman Diane	Officer	未知	-	-	-	-